Review



ntera 2 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ATCC ntera 2 cells
    Ntera 2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/pmc06746891-135-0-3?v=ATCC
    Average 90 stars, based on 3 article reviews
    ntera 2 cells - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    proteintech cat 21973 1 ap rrid ab 11124728  (Proteintech)
    93
    Proteintech proteintech cat 21973 1 ap rrid ab 11124728
    Proteintech Cat 21973 1 Ap Rrid Ab 11124728, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/pmc12438011-100-22-22?v=Proteintech
    Average 93 stars, based on 1 article reviews
    proteintech cat 21973 1 ap rrid ab 11124728 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    gfra2  (Proteintech)
    93
    Proteintech gfra2
    Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , <t>GFRA2</t> , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.
    Gfra2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/pmc12438011-100-20-22?v=Proteintech
    Average 93 stars, based on 1 article reviews
    gfra2 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    pa5 21903 rrid ab 11154802  (Proteintech)
    93
    Proteintech pa5 21903 rrid ab 11154802
    Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , <t>GFRA2</t> , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.
    Pa5 21903 Rrid Ab 11154802, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/bio_rxiv__2024__12__21__629891-221-17-21?v=Proteintech
    Average 93 stars, based on 1 article reviews
    pa5 21903 rrid ab 11154802 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier
    anti-rsv reference serum nr-21973  (BEI Resources)
    90
    BEI Resources anti-rsv reference serum nr-21973
    Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , <t>GFRA2</t> , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.
    Anti Rsv Reference Serum Nr 21973, supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/pmc11619414-164-0-7?v=BEI+Resources
    Average 90 stars, based on 1 article reviews
    anti-rsv reference serum nr-21973 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    human reference immunoglobulin to rsv (nr-21973; sample 1)  (BEI Resources)
    90
    BEI Resources human reference immunoglobulin to rsv (nr-21973; sample 1)
    Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , <t>GFRA2</t> , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.
    Human Reference Immunoglobulin To Rsv (Nr 21973; Sample 1), supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/pm31708177-88-24-4?v=BEI+Resources
    Average 90 stars, based on 1 article reviews
    human reference immunoglobulin to rsv (nr-21973; sample 1) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    polyclonal pool of anti-rsv antibodies nr-21973  (BEI Resources)
    90
    BEI Resources polyclonal pool of anti-rsv antibodies nr-21973
    Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , <t>GFRA2</t> , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.
    Polyclonal Pool Of Anti Rsv Antibodies Nr 21973, supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/pmc07548429-175-4-10?v=BEI+Resources
    Average 90 stars, based on 1 article reviews
    polyclonal pool of anti-rsv antibodies nr-21973 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    ntera 2 cells  (ATCC)
    90
    ATCC ntera 2 cells
    Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , <t>GFRA2</t> , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.
    Ntera 2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/21973/pmc06746891-135-0-3?v=ATCC
    Average 90 stars, based on 1 article reviews
    ntera 2 cells - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , GFRA2 , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.

    Journal: The Journal of Pathology

    Article Title: Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions

    doi: 10.1002/path.6457

    Figure Lengend Snippet: Identification of a spatially defined NRTN – GRFA2/RET interaction and experimental validation in NB cells. (A) Chord plot showing the number of predicted outgoing signaling interactions from the AC‐like cluster. Number of interactions with NE1 and NE2‐CA and examples of common interactions given. See supplementary material, Table for detailed results. (B) Spatial gene expression plots showing NRTN , GFRA2 , and RET expression in sections, as indicated. (C) Bar plot indicating percentages of NRTN expressing primary NB tumors with high (>90th percentile), intermediate, and low (<10th percentile) AC‐like signatures, as indicated. p values calculated using chi‐square test. (D) Kaplan–Meier survival plots comparing overall survival between NB patients with high (>90th percentile), intermediate (10th–90th percentile), and low (<10th percentile) gene expression, as indicated. p values calculated using the log rank test. (E) Western blot showing expression of GFRA2 in four different NB cell lines, as indicated. Normalized densitometry values indicated below each blot. (F, G) Time‐dependent effect of NRTN (100 ng/ml; n = 3) and/or selpercatinib (500 n m ; n = 3) application on (F) relative wound density (RWD; measured using a scratch/wound migration assay), and (G) cell growth (measured on Incucyte S3 system) on different NB cell lines, as indicated. p values for indicated timepoints calculated using an unpaired, two‐sided Student's t ‐test.

    Article Snippet: Samples were subjected to western blotting analyses using the following antibodies: PITPNM3 (1:1,000) (Thermo Fisher Scientific, Cat# PA5‐21903, RRID:AB_11154802 ), GFRA2 (1:1,000) (Proteintech, Cat# 21973‐1‐AP, RRID:AB_11124728 ), and beta‐actin (1:10,000) (Cell Signaling Technology, Danvers, MA, USA; Cat# 4970, RRID:AB_2223172 ).

    Techniques: Biomarker Discovery, Gene Expression, Expressing, Western Blot, Migration